These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2476547

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior of pigeons.
    Witkin JM, Mansbach RS, Barrett JE, Bolger GT, Skolnick P, Weissman B.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):970-7. PubMed ID: 2891840
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms.
    Barrett JE, Witkin JM, Mansbach RS, Skolnick P, Weissman BA.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1009-13. PubMed ID: 2875168
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B, Veiga S, Goument B, Peglion JL, Spedding M, Brocco M.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [Abstract] [Full Text] [Related]

  • 8. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF, Koolhaas JM.
    Eur J Pharmacol; 2005 Dec 05; 526(1-3):125-39. PubMed ID: 16310183
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E, Robert JP, Young AR, MacKenzie ET.
    J Pharmacol Exp Ther; 1989 Jun 05; 249(3):879-89. PubMed ID: 2732950
    [Abstract] [Full Text] [Related]

  • 10. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I, Nobler MS, Frazer A.
    J Pharmacol Exp Ther; 1984 Jan 05; 228(1):133-9. PubMed ID: 6694097
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A, Sebben M, Bockaert J.
    Mol Pharmacol; 1988 Feb 05; 33(2):178-86. PubMed ID: 2828913
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J.
    Mol Pharmacol; 1988 Dec 05; 34(6):880-7. PubMed ID: 2849052
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY, Xing GG, Qu XX, Xu IS, Han JS, Wan Y.
    J Pharmacol Exp Ther; 2007 Jun 05; 321(3):1046-53. PubMed ID: 17329553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.